Group One Trading
CPIX icon

Group One Trading’s Cumberland Pharmaceuticals CPIX Stock Holding History

Group One Trading’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-7,742
Closed -$22.9K – 8262
2025
Q3 		$24.2K Sell
7,742
-480
-6% -$1.59K ﹤0.01% 6554
2025
Q2 		$27.5K Buy
+8,222
New +$38.9K ﹤0.01% 6060
2013
Q4 		– Sell
-365
Closed -$2K – 5251
2013
Q3 		$2K Hold
365
– – ﹤0.01% 4945
2013
Q2 		$2K Buy
+365
New +$1.82K ﹤0.01% 4884

Other funds holding CPIX

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Group One Trading's CPIX Position: Q4 2025 in Review

Group One Trading sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2025, closing a stake of 7,742 shares — an estimated $22.9K sold.

Group One Trading first reported a position in CPIX in Q2 2013 and held it in 4 quarters. The position peaked at $27.5K in Q2 2025. 27 funds tracked by Wall St. Rank hold CPIX as of Q4 2025.

  • Group One Trading reported no remaining Cumberland Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 7,742 Cumberland Pharmaceuticals shares in Q4 2025, an estimated $22.9K.
  • Group One Trading first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 4 quarters.
  • Group One Trading's Cumberland Pharmaceuticals position peaked at $27.5K in Q2 2025.
  • 27 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.